Literature DB >> 24122815

Psychosocial factors affecting uptake of prenatal genetic testing: a pilot study.

Monica Pivetti1, Giannino Melotti, Davide Morselli, Mariangela Olivieri.   

Abstract

OBJECTIVE: This study aims to explore the psychosocial factors which influenced the undergoing of prenatal genetic testing (PGT) in a sample of pregnant women.
METHOD: An online questionnaire was emailed to a convenient sample of 105 pregnant women, recruited from among those attending two antenatal education programmes and via snowball sampling.
RESULTS: A minority of respondents underwent chorionic villous sampling and amniocentesis (12 and 11, respectively). Advanced maternal age was related to undertaking PGT. The path analysis model (χ(2) (16, N = 97) = 19.01, ns; TLI = 0.95; RMSEA = 0.04; WRMR = 0.64) confirmed that three dimensions, namely having a more supporting attitude towards PGT (β = 0.54, p < 0.001), perceiving PGT as reliable (β = 0.29, p < 0.05) and the request for more scientific information (β = 0.22, p < 0.01), related to test uptaking.
CONCLUSION: Empirical researches investigating pregnant women's beliefs and attitudes relating to actual test uptake could help genetic counsellors and policy makers to better understand their client's profile in relation to the determining factors affecting the undertaking of PGT.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 24122815     DOI: 10.1002/pd.4248

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Expert Knowledge Influences Decision-Making for Couples Receiving Positive Prenatal Chromosomal Microarray Testing Results.

Authors:  M A Rubel; A Werner-Lin; F K Barg; B A Bernhardt
Journal:  Cult Med Psychiatry       Date:  2017-09

2.  The limited effect of information on Israeli pregnant women at advanced maternal age who decide to undergo amniocentesis.

Authors:  Julia Grinshpun-Cohen; Talya Miron-Shatz; Michal Berkenstet; Elon Pras
Journal:  Isr J Health Policy Res       Date:  2015-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.